Yabao Pharmaceutical Group Co., Ltd.

Currently, Yabao Group has 5 branches and 13 subsidiaries with more than 6000 employees. Yabao is the first public listed company of pharmaceuticals in Shanxi Province (stock code: 600351). The brand Yabao has been rated as Chinese Famous Brand.

Yabao Group is one of the TOP 50 on Chinese traditional drug manufacturing in China, has a total asset of RMB 2.5 billion; turnover of RMB 2.2 billion until end of 2012 . There are totally more than 300 products in this group. Yabao Group has set up strong brand among drug products for cardio-cerebrovascular disease, pediatric disease and gynecological disease. With advanced facilities, equipments and instruments, Yabao Group has a strong ability for R&D and manufacturing.

The Group Company has been mainly developing modern Chinese medicine and new chemical drug delivery system, having a dominant position in drugs for CCVD (Cardiac Cerebral Vascular Disease), children and women, striving to be the top brand of CCD (Cardiac Cerebral Disease) drugs of the nation.

The Group Company has been constructing production lines according with the standards of cGMP, introducing internationally advanced management system, aiming to produce better products, provide better service, enlarge our brand and strengthen our company and make Yabao an international company With theglobal image